| Primary |
| Acne |
79.8% |
| Rosacea |
5.5% |
| Product Used For Unknown Indication |
3.8% |
| Acne Cystic |
2.2% |
| Folliculitis |
1.6% |
| Acne Vulgaris |
0.5% |
| Actinic Keratosis |
0.5% |
| Alopecia |
0.5% |
| Decubitus Ulcer |
0.5% |
| Dermatitis |
0.5% |
| Dermatitis Allergic |
0.5% |
| Eczema |
0.5% |
| Ill-defined Disorder |
0.5% |
| Menstrual Disorder |
0.5% |
| Rhinorrhoea |
0.5% |
| Skin Disorder |
0.5% |
| Subcutaneous Abscess |
0.5% |
| Wound Secretion |
0.5% |
|
| Urticaria |
18.3% |
| Benign Intracranial Hypertension |
7.0% |
| Vision Blurred |
7.0% |
| Vomiting |
7.0% |
| Weight Decreased |
7.0% |
| Lupus-like Syndrome |
5.6% |
| Rash |
5.6% |
| Convulsion |
4.2% |
| Pain |
4.2% |
| Serum Sickness |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Alopecia |
2.8% |
| Autoimmune Hepatitis |
2.8% |
| Drug Hypersensitivity |
2.8% |
| Electrocardiogram P Wave Abnormal |
2.8% |
| Extrasystoles |
2.8% |
| Headache |
2.8% |
| Hydrocephalus |
2.8% |
| Hypersensitivity |
2.8% |
| Mixed Deafness |
2.8% |
|
| Secondary |
| Acne |
76.2% |
| Dry Skin |
9.5% |
| Attention Deficit/hyperactivity Disorder |
4.8% |
| Blood Cholesterol Increased |
4.8% |
| Hypersensitivity |
4.8% |
|
| Acute Hepatic Failure |
9.1% |
| Folliculitis |
9.1% |
| Hepatic Failure |
9.1% |
| Hepatitis Cholestatic |
9.1% |
| Nausea |
9.1% |
| Rosacea |
9.1% |
| Skin Odour Abnormal |
9.1% |
| Throat Tightness |
9.1% |
| Urticaria |
9.1% |
| Vomiting |
9.1% |
| Wrong Drug Administered |
9.1% |
|
| Concomitant |
| Acne |
31.6% |
| Product Used For Unknown Indication |
19.5% |
| Osteoporosis |
6.3% |
| Contraception |
4.7% |
| Hypersensitivity |
4.3% |
| Premenstrual Syndrome |
3.9% |
| Breast Cancer |
3.1% |
| Crohn's Disease |
3.1% |
| Osteopenia |
3.1% |
| Pain |
3.1% |
| Acne Cystic |
2.7% |
| Headache |
2.7% |
| Psoriasis |
2.0% |
| Anxiety |
1.6% |
| Attention Deficit/hyperactivity Disorder |
1.6% |
| Hypothyroidism |
1.6% |
| Post Coital Contraception |
1.6% |
| Back Pain |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Dermatitis Papillaris Capillitii |
1.2% |
|
| Pulmonary Embolism |
17.0% |
| Injection Site Pain |
6.4% |
| Nausea |
6.4% |
| Pain |
6.4% |
| Vomiting |
6.4% |
| Acne |
4.3% |
| Arthritis |
4.3% |
| Cholecystitis Chronic |
4.3% |
| Depression |
4.3% |
| Drug Ineffective |
4.3% |
| Dyspnoea |
4.3% |
| Injection Site Swelling |
4.3% |
| Menstruation Irregular |
4.3% |
| Mood Altered |
4.3% |
| Rash |
4.3% |
| Temporomandibular Joint Syndrome |
4.3% |
| Thrombophlebitis Superficial |
4.3% |
| Abdominal Pain |
2.1% |
| Abnormal Behaviour |
2.1% |
| Alopecia |
2.1% |
|
| Interacting |
| Acne |
50.0% |
| Post-traumatic Stress Disorder |
50.0% |
|
| Off Label Use |
66.7% |
| Drug Interaction |
33.3% |
|
